|
|
|
Download StockRing Free Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech
|
|
BUY DOW 30+: WSM WPZ VFC UPS UNP ENERGY: WES TTI TCP SPN REXX HEALTH: WX UTMD THOR STJ SNY
FINANCE: VR TFSL PVD PRA OB SERVICES: WIN ULTA TKC TDS SYY TECH: WDC SWIR RENN ONNN NTAP
SELL DOW 30+: XEL WMT WERN VALE UTX ENERGY: YZC YPF XOM XEC XCO HEALTH: ZTS ZMH XRAY XOMA WST
FINANCE: ZION Y XLI XLB WTM SERVICES: WYNN WYN WTW WMT WM TECH: YNDX XRX XLNX WIT WCC
Our FREE iPhone App with Buy-Sell-Hold ratings for 1,200 stocks:
iPhone App Buy-Sell-Hold Ratings for 5-5-2013
|
|
|
6/20/2013 Thursday, June 20, 2013 (Irvine, California) Today StockRing.com Recommendation is to "HOLD"for Salix Pharmaceuti (NASDAQ:SLXP) Stock.
SLXP stock opening price was $66.3 per share.
Current price of NASDAQ:SLXP Stock is $66.42 per share
and it is
$0.00, (0.00%) today
and it was trading in the daily range of $66.26 - 66.53 per share.
Current Bid Price for (NASDAQ:SLXP) stock is $0.00 and the Ask Price is $0.00. In the last 52 weeks
SLXP stock was trading in the range of $37.52 - 55.99. 50-Day Moving Average for (NASDAQ:SLXP) stock is
$49.74 and 200-Day Moving Average is $45.18. On average analysts predict that One Year Target Estimated price for
(NASDAQ:SLXP) stock is $65.17.
Salix Pharmaceuti (NASDAQ:SLXP) is rated as a wait on 6/13/2013 7:04:57 AM.
Salix Pharmaceuti (NASDAQ:SLXP) Market capitalization is $4.072B. (NASDAQ:SLXP) stock average daily volume is
487,089 shares per day.
However, on last trading session of Jun 19, 2012
SLXP stock traded shares.
Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:SLXP) stock is 3.60.
On previous trading session SLXP Stock closed at $66.42 per share.
Last year Salix Pharmaceuti (NASDAQ:SLXP) before taxes (EBITDA) (ttm) earned $249.4M on total revenue of $766.9M.
Earnings Per Share - EPS (ttm) for SLXP stock is 1.22.
Also, (NASDAQ:SLXP) Stock Price Per Earnings ratio - P/E is 54.62.
Thus, (NASDAQ:SLXP) Stock Price/Sales (ttm) ratio is 5.31 and Price/Book (mrq) ratio is 6.93.
(NASDAQ:SLXP) Stock does NOT PAY any dividend.
So at this time (NASDAQ:SLXP) Stock maintains Trailing Annual Dividend Rate at 0.00
.
|
StockRing Recommendations for Salix Pharmaceuti (NASDAQ:SLXP) Stock are updated daily here
http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=SLXP
At this time
StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a
BUY or
SUPER BUY rating.
If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have
a SELL or
SUPER SELL rating.
If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech
sectors on your iPhone, then please
download Buy-Sell-Hold iPhone App here:
|
NASDAQ:SLXP Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max
Options More Info
|
6/20/2013
1 Year Stock market price chart for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Thursday, June 20, 2013
|
 | |
| 1 Year SLXP |
1 Year Dow Jones |
 |
 |
| 1 Year Nasdaq |
1 Year S&P 500 |
 |
 |
|
|
6/20/2013
5 days Stock market price chart for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Thursday, June 20, 2013
|
| |
| 5 Days SLXP |
5 Days Dow Jones |
 |
 |
| 5 Days Nasdaq |
5 Days S&P 500 |
 |
 |
|
|
|
|
|
EUROs for $1 DOLLAR: 30 days | |
| |
|
NASDAQ:SLXP Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max
Options More Info
|
| Last Trade: |
66.42 |
| Trade Time: |
Jun 19 |
| Change: |
0.00, (0.00%) |
| Prev Close: |
66.42 |
| Open: |
66.3 |
| Bid: |
0.00 |
| Ask: |
0.00 |
| 1y Target Est: |
$65.17 |
| 50-Day Moving Average: |
49.74 |
200-Day Moving Average:
|
45.18 |
| Short Ratio: |
3.60 |
| Trailing Annual Dividend Rate: |
0.00
|
|
| Day's Range: |
66.26 - 66.53 |
| 52wk Range: |
37.52 - 55.99 |
| Volume: |
|
| Avg Vol: |
487,089 |
| Market Cap: |
4.072B |
| P/E (ttm): |
54.62 |
| EPS (ttm): |
1.22 |
| Div & Yield: |
0.00 (N/A%) |
| Revenue (ttm): |
766.9M |
| Earnings before Tax (EBITDA) (ttm): |
249.4M |
| Price/Sales (ttm): |
5.31 |
| Price/Book (mrq): |
6.93 |
|
Salix Pharmaceuticals Upgraded by Zacks to "Outperform" (SLXP)
Daily Political - 16 hours ago
Salix Pharmaceuticals, Ltd. logo Salix Pharmaceuticals (NASDAQ: SLXP) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research report issued on Wednesday, Analyst Ratings Network reports.
SALIX PHARMACEUTICALS, LTD. : New Breakthroughs Allow Companies to ...
4-traders (press release) - Jun 6, 2013
Today, Wall Street Reports announced new research reports highlighting Perrigo Company (NASDAQ: PRGO), Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), Actavis Inc. (NYSE: ACT), Mylan, Inc. (NASDAQ: MYL), and Salix Pharmaceuticals, Ltd.
|
|
Valeant Raising Funds - Analyst BlogNASDAQValeant will issue approximately 23.5 million shares for $85.00 per share and thereby raise approximately $2.0 billion. In addition, the company has granted an option to the underwriters of the offering to purchase additional common shares equal to up ...and more » |
|
|
| |
|
|
Copyright
© 2012 StockRing.com. All rights reserved.
Subscriber Agreement Privacy Agreement Stocks MutualFunds
Data and information is provided for informational purposes only, and is not intended
for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any
actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information
found therein.
|
| |
